Chemoinformaics analysis of Neoplatyphylline
| Molecular Weight | 337.416 | nRot | 0 |
| Heavy Atom Molecular Weight | 310.2 | nRig | 22 |
| Exact Molecular Weight | 337.189 | nRing | 3 |
| Solubility: LogS | -2.315 | nHRing | 3 |
| Solubility: LogP | 1.241 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 53.1734 |
| nHD | 1 | BPOL | 34.0046 |
| QED | 0.53 |
| Synth | 4.989 |
| Natural Product Likeliness | 2.719 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.963 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.711 |
| MDCK | 0.0000369 |
| BBB | 0.687 |
| PPB | 0.275621 |
| VDSS | 1.368 |
| FU | 0.55923 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.101 |
| CYP2c19-inh | 0.081 |
| CYP2c19-sub | 0.775 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.109 |
| CYP2d6-inh | 0.636 |
| CYP2d6-sub | 0.528 |
| CYP3a4-inh | 0.184 |
| CYP3a4-sub | 0.431 |
| CL | 5.836 |
| T12 | 0.716 |
| hERG | 0.104 |
| Ames | 0.018 |
| ROA | 0.019 |
| SkinSen | 0.812 |
| Carcinogencity | 0.639 |
| EI | 0.069 |
| Respiratory | 0.063 |
| NR-Aromatase | 0.414 |
| Antiviral | Yes |
| Prediction | 0.873398 |